Skip to content
Home/Companies/Pharma/Abacus Pharmaceuticals
Abacus Pharmaceuticals

Abacus Pharmaceuticals

Pharma·USA·Active
Entry
–
Hold
–
Status
Active

Who owns Abacus Pharmaceuticals?

Abacus Pharmaceuticals is an American Pharma company, currently owned by The Carlyle Group.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQUSA
SectorPharma
Websiteabacuspharma.com

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
HospitalityUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to ASSA ABLOY
Amrod
Amrod
Exited 2023
ConsumerUS
to Oppenheimer Partners Limited
CMC Networks
CMC Networks
Active
TelecomSouth Africa
Every Man Jack
Every Man Jack
Active
ConsumerUS

More PE-backed in Pharma

Comparable pharma deals from other GPs.

AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Active
Cathay CapitalFrance

Questions

Who owns Abacus Pharmaceuticals?

Abacus Pharmaceuticals is currently owned by The Carlyle Group, through Carlyle Sub-Saharan Africa Fund.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue